Jason Fung: What Happened to “Statins Save Lives”?
Jason Fung, Physician, Nephrologist, shared a post on X about a recent article by Jes S Lindholt et al., published in European Heart Journal, adding:
“What happened to ‘statins save lives’?
In this 31,000 person RCT over 7 years, CVD screening put 44.33% of people on statins (compared to 30.25% in non screening) but prevented neither deaths nor CV events (HR 0.96).
Funny how I don’t see this trial ever being discussed by cardiologists. One major difference with this trial compared to so many other statin trials is that it is not funded by a statin maker.”
Title: Outcomes of cardiovascular screening in men aged 60–64 years: the DANCAVAS II trial
Authors: Jes S Lindholt, Anne Mejldal, Lars M. Rasmussen, Jess Lambrechtsen, Flemming H. Steffensen, Lars Frost, Kenneth Egstrup, Grazina Urbonaviciene, Martin Busk, Marek Karon, Axel Cosmus Pyndt Diederichsen
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters